|
|
Learning Objective:
By the end of the presentation participants will be able to:
1. State behavioral risks for transmission of hepatitis A, B, and C.
2. Determine how to utilize curriculum with target audience of drug treatment providers and/or HIV prevention staff.
Background:
Injection drug use (IDU) continues to play a large role in transmission of blood-borne diseases, such as HIV, and hepatitis B and C (HCV). Approximately 25% of HIV-infected persons are co-infected with HCV. Risk groups for HIV and hepatitis overlap significantly. HIV service providers had expressed a need for hepatitis information to better enable them to educate their clients. In NJ, the topic of hepatitis has only recently begun to receive attention by HIV and drug treatment providers.
Setting:
Participants' workplaces and community educational settings.
Population e.g. API Youth, MSM, IDU:
Participant population: HIV grantees, drug treatment and corrections staff (Federal prisons, state facilities and county jails). Target population is IDU and others at risk for hepatitis infections.
Project Description:
The NJ Department of Health and Senior Services' Division of HIV/AIDS and Communicable Disease Service, with assistance from The Academy for Educational Development, developed a curriculum: “Integrating Hepatitis Prevention Messages into HIV Prevention Services,” based on HIV/hepatitis modules used in New Mexico, New York City, and other jurisdictions. Training materials include slides, participant manuals, pretest and posttest, and games. Trainings have been provided over the past 15 months to 250 participants, with very favorable response.
Results/Lessons Learned:
Integration of hepatitis messages into HIV prevention activities is feasible and necessary and optimizes education on risk and resources, including vaccination programs. Training needs to be flexible to accommodate audience time constraints, such as those of methadone treatment staff. A variation of this training is planned for use with clients.
See more of Poster Session #1
See more of The 2005 National Viral Hepatitis Prevention Conference